These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38490344)

  • 1. First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort.
    Bergkamp SC; Kanagasabapathy T; Gruppen MP; Kuijpers TW; Rashid AN; van den Berg JM; Schonenberg-Meinema D
    Clin Immunol; 2024 May; 262():110172. PubMed ID: 38490344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS).
    Smith EMD; Aggarwal A; Ainsworth J; Al-Abadi E; Avcin T; Bortey L; Burnham J; Ciurtin C; Hedrich CM; Kamphuis S; Lambert L; Levy DM; Lewandowski L; Maxwell N; Morand E; Ozen S; Pain CE; Ravelli A; Saad Magalhaes C; Pilkington C; Schonenberg-Meinema D; Scott C; Tullus K; Beresford MW;
    Clin Immunol; 2023 May; 250():109296. PubMed ID: 36934849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE.
    Cody EM; Wilson BE; Ogbu EA; Huggins JL; Chen C; Qiu T; Ting TV; Flores F; Huang B; Brunner HI
    Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37253553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal disease- and steroid-related damage among adults with childhood-onset systemic lupus erythematosus.
    Heshin-Bekenstein M; Trupin L; Yelin E; von Scheven E; Yazdany J; Lawson EF
    Semin Arthritis Rheum; 2019 Oct; 49(2):267-272. PubMed ID: 31235075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force.
    Smith EMD; Aggarwal A; Ainsworth J; Al-Abadi E; Avcin T; Bortey L; Burnham J; Ciurtin C; Hedrich CM; Kamphuis S; Lambert L; Levy DM; Lewandowski L; Maxwell N; Morand E; Özen S; Pain CE; Ravelli A; Saad Magalhaes C; Pilkington C; Schonenberg-Meinema D; Scott C; Tullus K; Beresford MW;
    Clin Immunol; 2024 Jun; 263():110214. PubMed ID: 38604255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of follow-up adherence on disease activity in childhood-onset systemic lupus erythematosus (cSLE).
    Nelson MC; Mosley C; Villacis-Nunez DS; Rouster-Stevens K; Thakral A
    Lupus; 2023 May; 32(6):799-803. PubMed ID: 37125694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease presentation of 1312 childhood-onset systemic lupus erythematosus: influence of ethnicity.
    Fiorot FJ; Islabão AG; Pereira RM; Terreri MT; Saad-Magalhães C; Novak GV; Molinari BC; Sakamoto AP; Aikawa NE; Campos LM; Peracchi OA; Appenzeller S; Ferriani VP; Silva MF; Fonseca AR; Sztajnbok FR; Paim LB; Fraga MM; Okuda EM; Bica BE; Sena EG; Moraes AJ; Rolim AM; Spelling PF; Scheibel IM; Cavalcanti AS; Matos EN; Robazzi TC; Guimarães LJ; Santos FP; Ramos VC; Carneiro-Sampaio M; Bonfá E; Silva CA;
    Clin Rheumatol; 2019 Oct; 38(10):2857-2863. PubMed ID: 31209708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    Joo YB; Park SY; Won S; Bae SC
    J Rheumatol; 2016 Aug; 43(8):1490-7. PubMed ID: 27252431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-up.
    Schonenberg-Meinema D; Bergkamp SC; Nassar-Sheikh Rashid A; Gruppen MP; Middelkamp-Hup MA; Armbrust W; Dolman K; Hak AE; Hissink Muller PCE; van Onna M; Swart JF; Kuijpers TW; Kamphuis SSM; Smith V; van den Berg JM
    Lupus Sci Med; 2022 Feb; 9(1):. PubMed ID: 35140136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus.
    Smith EMD; Tharmaratnam K; Al-Abadi E; Armon K; Bailey K; Brennan M; Ciurtin C; Gardner-Medwin J; Haslam KE; Hawley D; Leahy A; Leone V; Malik G; McLaren Z; Pilkington C; Ramanan AV; Rangaraj S; Ratcliffe A; Riley P; Sen E; Sridhar A; Wilkinson N; Hedrich CM; Jorgensen A; Beresford MW
    Rheumatology (Oxford); 2022 Aug; 61(8):3378-3389. PubMed ID: 34894234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
    Na Nakorn K; Piyaphanee N; Sukharomana M; Pinpatanapong R; Charuvanij S
    Clin Rheumatol; 2023 Jun; 42(6):1655-1664. PubMed ID: 36780064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study.
    Koutsonikoli A; Trachana M; Heidich AB; Galanopoulou V; Pratsidou-Gertsi P; Garyphallos A
    Rheumatol Int; 2015 Jul; 35(7):1225-32. PubMed ID: 25586653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study.
    Sit JKK; Chan WKY
    Pediatr Rheumatol Online J; 2018 Sep; 16(1):56. PubMed ID: 30201026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European Consensus Lupus Activity Measurement is sensitive to change in disease activity in childhood-onset systemic lupus erythematosus.
    Brunner HI; Silverman ED; Bombardier C; Feldman BM
    Arthritis Rheum; 2003 Jun; 49(3):335-41. PubMed ID: 12794788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
    Cho J; Shen L; Huq M; Kandane-Rathnayake R; Golder V; Louthrenoo W; Chen YH; Hamijoyo L; Luo SF; Wu YJ; Zamora L; Li Z; Sockalingam S; Katsumata Y; Harigai M; Hao Y; Zhang Z; Basnayake D; Chan M; Kikuchi J; Takeuchi T; Bae SC; Oon S; O'Neill S; Goldblatt F; Ng KPL; Law A; Tugnet N; Kumar S; Tee C; Tee M; Ohkubo N; Tanaka Y; Navarra SV; Lau CS; Hoi A; Morand EF; Nikpour M; Lateef A;
    Lancet Rheumatol; 2023 Oct; 5(10):e584-e593. PubMed ID: 38251484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison among ACR1997, SLICC and the new EULAR/ACR classification criteria in childhood-onset systemic lupus erythematosus.
    Rodrigues Fonseca A; Felix Rodrigues MC; Sztajnbok FR; Gerardin Poirot Land M; Knupp Feitosa de Oliveira S
    Adv Rheumatol; 2019 May; 59(1):20. PubMed ID: 31092290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between the disease characteristics in adult-onset and childhood-onset systemic lupus erythematosus in Egyptian patients attending a large university hospital.
    El-Garf K; El-Garf A; Gheith R; Badran S; Salah S; Marzouk H; Farag Y; Khalifa I; Mostafa N
    Lupus; 2021 Feb; 30(2):211-218. PubMed ID: 33175664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls.
    Schonenberg-Meinema D; Bergkamp SC; Nassar-Sheikh Rashid A; van der Aa LB; de Bree GJ; Ten Cate R; Cutolo M; Hak AE; Hissink Muller PC; van Onna M; Kuijpers TW; Smith V; van den Berg JM
    Lupus; 2021 Apr; 30(5):818-827. PubMed ID: 33657918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the performance of ACR, SLICC and EULAR/ACR classification criteria in childhood onset systemic lupus erythematosus.
    Abdwani R; Al Masroori E; Abdullah E; Al Abrawi S; Al-Zakwani I
    Pediatr Rheumatol Online J; 2021 Sep; 19(1):141. PubMed ID: 34503539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study.
    Wang D; Shan C; Liu J; Zhang R; Zhu G; Gao T; Chang H; Gao S; Bai C; Nie N; Zhang Q; Lin Y
    Front Immunol; 2022; 13():1067721. PubMed ID: 36591249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.